Peter Greaney
Keine laufenden Positionen mehr
Profil
Peter Greaney worked as the Director of Business Development and Operations at Celgene Corp.
from 2006 to 2018.
He also worked as the Head of Corporate Development at ADC Therapeutics SA. Prior to his professional experience, he earned an undergraduate degree from the University of East Anglia and a doctorate from the University of Nottingham.
Ehemalige bekannte Positionen von Peter Greaney
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | Geschäftsführer | 01.01.2018 |
| ADC THERAPEUTICS SA | Corporate Officer/Principal | - |
Ausbildung von Peter Greaney
| University of East Anglia | Undergraduate Degree |
| The University of Nottingham | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADC THERAPEUTICS SA | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
